Mass spectrometry has been applied in many biomedical researches including proteomics, metabolomics, cancer markers, microorganism diagnosis, and new born screening. To facilitate further development of mass spectrometry for clinical medicine, the Journal of Food and Drug Analysis (JFDA) published a special issue entitled “Mass Spectrometry for Clinical Diagnosis" in 2019. The objective of the special issue is to introduce recent advances of preclinical and clinical researches as well as regulatory perspectives by using modern mass spectrometry.
http://www.fda.gov.tw/TC/publishJFDA.aspx?id=52

Attachment File:
● Electronic DM